Prevention of fungal infection in the early period after liver transplantation
Abstract
This article describes the risk and incidence of fungal infections in the early period after liver transplantation, their diagnosis, treatment and prevention. After liver transplant patients have a higher risk of developing invasive fungal infection. The presence of high - risk factors is an absolute indication for prophylactic antifungal medicine.
About the Authors
M. Sh. Khubutiya
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
S. V. Zhuravel'
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
T. V. Chernen'kaya
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
G. K. Ospanova
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
A. I. Bazhenov
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
N. K. Kuznetsova
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
I. I. Utkina
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow
Russian Federation
Russian Federation
References
1. Kawecki D., Chmura A., Pacholczyk M., et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009; 15 (12): CR628– CR637.
2. Tenza E., Bernardo C.G., Escudero D., et al. Liver transplantation complications in the intensive care unit and at 6 months. Transplant Proc. 2009; 41 (3): 1050– 1053.
3. Watt K.D., Pedersen R.A., Kremers W.K., et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK longterm follow-up study. Am J Transplant. 2010; 10 (6): 1420–1427.
4. Neofytos D., Fishman J.A., Horn D., et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010; 12 (3): 220–229.
5. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003; 17 (1): 113–134.
6. Kollef M., Micek S., Hampton N., et al. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012; 54 (12): 1739–1746.
7. Person A.K., Kontoyiannis D.P., Alexander B.D. Fungal infections in transplant and oncology patients. Infect Dis Clin North Am. 2010; 24 (2): 439–459.
8. Cruciani M., Mengoli C., Malena M., et al. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 2006; 12 (5): 850–858.
9. Horn D.L., Neofytos D., Anaissie E.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009; 48 (12): 1695–1703.
10. Hadley S., Huckabee C., Pappas P.G., et al. Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis. 2009; 11 (1): 40–48.
11. Fortún J., Martín–Dávila P., Montejo M., et al. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation. 2009; 87 (3): 424–435.
12. Zhuravel' S.V., Chugunov A.O., Chernen'kaya T.V. Problema sistemnogo kandidoza posle transplantatsii solidnykh organov [The problem is systemic candidiasis after transplantation of solid organs]. Transplantologiya. 2012; 3: 42–48. (In Russian).
13. Collins L.A., Samore M.H., Roberts M.S., et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994; 170 (3): 644–652.
14. Sharpe M.D., Ghent C., Grant D., et al. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation. 2003; 76 (6): 977–983.
15. Addeo P., Saouli A.C., Woehl-Jaegle M.L., et al. Candida albicans arteritis transmitted by preservation fluid after liver transplantation. Ann Transplant. 2014; 19: 64–67.
16. Curtis L. Better hospital nutrition needed to reduce morbidity and mortality from fungal infections. Crit Care Med. 2010; 38 (12): 2428–2429.
17. Pappas P.G., Alexander B.D., Andes D.R., et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50 (8): 1101–1111.
18. Fishman J.A. Infection in solid–organ transplant recipients. N Engl J Med. 2007; 357 (25): 2601–2614.
19. Klimko N.N., ed. Diagnostika i lechenie mikozov v otdeleniyakh reanimatsii i intensivnoy terapii. Rossiyskie natsional'nye rekomendatsii [Diagnosis and treatment of fungal infections in the intensive care unit. Russian national recommendations]. Moscow: BORGES Publ., 2010. 87 p. (In Russian).
20. Shoham S., Marr K. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012; 7 (5): 639–655.
Review
For citations:
Khubutiya M.Sh., Zhuravel' S.V., Chernen'kaya T.V., Ospanova G.K., Bazhenov A.I., Kuznetsova N.K., Utkina I.I. Prevention of fungal infection in the early period after liver transplantation. Transplantologiya. The Russian Journal of Transplantation. 2016;(2):29-34.
Views:
687
Email this article 